Kopelman_2007_Int.J.Obes.(Lond)_31_494

Reference

Title : Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients - Kopelman_2007_Int.J.Obes.(Lond)_31_494
Author(s) : Kopelman P , Bryson A , Hickling R , Rissanen A , Rossner S , Toubro S , Valensi P
Ref : Int J Obes (Lond) , 31 :494 , 2007
Abstract : Kopelman_2007_Int.J.Obes.(Lond)_31_494
ESTHER : Kopelman_2007_Int.J.Obes.(Lond)_31_494
PubMedSearch : Kopelman_2007_Int.J.Obes.(Lond)_31_494
PubMedID: 16953261

Related information

Citations formats

Kopelman P, Bryson A, Hickling R, Rissanen A, Rossner S, Toubro S, Valensi P (2007)
Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients
Int J Obes (Lond) 31 :494

Kopelman P, Bryson A, Hickling R, Rissanen A, Rossner S, Toubro S, Valensi P (2007)
Int J Obes (Lond) 31 :494